A Probability-Based Approach to Selecting Patients with Lung Cancer for Pretreatment Invasive Staging

RATIONALE: There is an opportunity to better select patients with non-small cell lung cancer (NSCLC) for pretreatment invasive staging-reducing the overall number of procedures without missing nodal metastases any more often than guideline-recommended criterion-based strategies. Doing so may avoid unnecessary testing, procedure-related risks, procedure-related costs, and treatment delays, and it may increase guideline-concordant invasive staging. OBJECTIVE: We compared a probability-based selection strategy for invasive staging to criterion-based strategies recommended by the National Comprehensive Cancer Network (NCCN) and American College of Chest Physicians (ACCP). METHODS: A retrospective cohort study was conducted of patients with NSCLC, without evidence of stage IV disease, who underwent invasive staging, resection, or both. The probability-based strategy stratified patients into high- and low-probability groups-analogous to criterion-based strategies that steer high-probability patients to invasive staging. We selected a threshold for stratification that matches the frequency by which criterion-based strategies select patients with nodal disease for invasive staging. We compared these selection strategies in terms of the expected frequency of invasive staging and associated confidence intervals (CIs). RESULTS: Among 3,080 patients, 783 (25%, 95%CI 24-27%) had pathologically confirmed nodal disease. The NCCN criterion-based strategy had a 79% (95%CI 78-80%) overall expected frequency of invasive staging. This criterion-based strategy selected 94% (95%CI 92-95%) of patients with true nodal disease to undergo invasive staging and selected 74% (95%CI 72-76%) of patients without true nodal disease to undergo invasive staging. The probability-based strategy had a fixed rate (94%) of selecting patients with true nodal disease for invasive staging-matching the performance of the criterion-based strategy. The probability-based strategy had a 74% (95%CI 73-76%) overall expected frequency of invasive staging and selected 68% (95%CI 66-70%) of patients without true nodal disease to undergo invasive staging. The probability-based strategy performed no differently than the ACCP criterion-based strategy. CONCLUSIONS: A probability-based selection strategy for pretreatment invasive staging may result in fewer overall procedures, without omitting them in patients with true nodal disease any more often than a NCCN criterion-based strategy. If externally validated, a probability-based selection strategy could offer an alternative approach to pretreatment invasive staging.

Authors

Institutions

Publication Details

Journal
Annals of the American Thoracic Society
Published
2026-11-13
DOI
https://doi.org/10.1093/annalsats/aaoag347
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Probability-Based Approach to Selecting Patients with Lung Cancer for Pretreatment Invasive Staging

Jeffrey B. Velotta, Robert T. Greenlee, Sarah E. Rudasill, Farhood Farjah et al.
1 links
Annals of the American Thoracic Society
Lung Cancer Diagnosis and Treatment
article

A Probability-Based Approach to Selecting Patients with Lung Cancer for Pretreatment Invasive Staging

Jeffrey B. Velotta, Robert T. Greenlee, Sarah E. Rudasill, Farhood Farjah, Robert H. Schmicker, Lori C. Sakoda, Douglas E. Wood, Patrick J. Heagerty, Gerard A. Silvestri, Christina S. Baik, Sudhakar N. J. Pipavath, Jing Zeng, Michael K. Gould, David Leroy Veenstra
article en

Abstract

RATIONALE: There is an opportunity to better select patients with non-small cell lung cancer (NSCLC) for pretreatment invasive staging-reducing the overall number of procedures without missing nodal metastases any more often than guideline-recommended criterion-based strategies. Doing so may avoid unnecessary testing, procedure-related risks, procedure-related costs, and treatment delays, and it may increase guideline-concordant invasive staging. OBJECTIVE: We compared a probability-based selection strategy for invasive staging to criterion-based strategies recommended by the National Comprehensive Cancer Network (NCCN) and American College of Chest Physicians (ACCP). METHODS: A retrospective cohort study was conducted of patients with NSCLC, without evidence of stage IV disease, who underwent invasive staging, resection, or both. The probability-based strategy stratified patients into high- and low-probability groups-analogous to criterion-based strategies that steer high-probability patients to invasive staging. We selected a threshold for stratification that matches the frequency by which criterion-based strategies select patients with nodal disease for invasive staging. We compared these selection strategies in terms of the expected frequency of invasive staging and associated confidence intervals (CIs). RESULTS: Among 3,080 patients, 783 (25%, 95%CI 24-27%) had pathologically confirmed nodal disease. The NCCN criterion-based strategy had a 79% (95%CI 78-80%) overall expected frequency of invasive staging. This criterion-based strategy selected 94% (95%CI 92-95%) of patients with true nodal disease to undergo invasive staging and selected 74% (95%CI 72-76%) of patients without true nodal disease to undergo invasive staging. The probability-based strategy had a fixed rate (94%) of selecting patients with true nodal disease for invasive staging-matching the performance of the criterion-based strategy. The probability-based strategy had a 74% (95%CI 73-76%) overall expected frequency of invasive staging and selected 68% (95%CI 66-70%) of patients without true nodal disease to undergo invasive staging. The probability-based strategy performed no differently than the ACCP criterion-based strategy. CONCLUSIONS: A probability-based selection strategy for pretreatment invasive staging may result in fewer overall procedures, without omitting them in patients with true nodal disease any more often than a NCCN criterion-based strategy. If externally validated, a probability-based selection strategy could offer an alternative approach to pretreatment invasive staging.

Annals of the American Thoracic Society
Marshfield Clinic (US), Kaiser Permanente (US), Medical University of South Carolina (US), University of California, San Francisco (US), University of Washington (US), Fred Hutch Cancer Center (US), Kaiser Permanente Bernard J. Tyson School of Medicine (US), Marshfield Clinic Research Foundation (US), Marshfield Clinic Research Institute (US)
Good health and well-being
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon